Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Contemp Clin Trials. 2018 Dec 2;76:104–111. doi: 10.1016/j.cct.2018.11.014

Table 1:

Eligibility Criteria

Inclusion Criteria
1. Apnea + Hypopnea Index (AHI) greater than ≥ 10
2. Type 2 diabetes mellitus
3. Age 18 years or older
4. Willing to be randomized to continuous positive airway pressure (CPAP) or sham-CPAP
Exclusion Criteria
1. Type 1 DM or pregnancy-induced diabetes
2. HbA1C <6.5% or > 11%
3. Sleep duration less than four hours per day
4. Change in diabetes medications during the previous 3 months
5. Acute medical or surgical conditions or hospitalization ≤ 3 months
6. Previous diagnosis of another sleep disorder
7. Oxygen or bi-level positive airway pressure (PAP) required
8. Not CPAP naïve
9. O2 sat. < 75% for > 25% of the ApneaLinkPlus® sleep study
10. Cardiovascular events noted during overnight titration sleep study
11. Persons in household with CPAP
12. History of near-miss or auto accident during last 12 months
13. Employed in safety sensitive job (i.e. truck driver or airline pilot)
14. Non-ambulatory
15. Regular use of hypnotic or alerting (e.g. modafinil) medications
16. Excessive consumption of alcohol
17. Claustrophobia to wearing mask
18. Unable to speak, read & write English
19. Pregnant or planning to become pregnant
20. Primary care provider